{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:59:22Z","timestamp":1788922762073,"version":"build-2803163510"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Despite modern immunosuppressive therapy, allograft rejection remains a major cause of solid organ transplant dysfunction. For clinical care, organ transplant function is routinely monitored by measuring biomarkers that, depending on the organ transplanted, include serum creatinine, N-terminal pro-hormone of brain natriuretic peptide (NT-proBNP), and aspartate aminotransferase. All can be measured easily in clinical chemistry laboratories. The main problem with these biomarkers is that they have a low sensitivity for the detection of allograft damage and are nonspecific for the detection of allograft rejection. To diagnose rejection, histologic examination of grafted tissue is necessary, which requires an invasive biopsy procedure. There is thus an unmet need in transplantation medicine for biomarkers that are specific for rejection, identify graft injury at an early stage, and may eventually overcome the need for a transplant biopsy. Recently, tremendous progress in the field of biomarkers has been made. In this narrative review, the potential of donor-derived cell-free DNA (ddcfDNA), cell-free nucleosomes, and extracellular vesicles to act as next-generation biomarkers for solid organ transplant is discussed. Based on the fact that cell content is released during rejection, these markers could serve as very specific biomarkers for allograft injury and rejection. These markers have the potential to improve rejection monitoring, evaluate the response to antirejection therapy, and may decrease the need for invasive procedures.<\/jats:p>","DOI":"10.1097\/ftd.0000000000000549","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T21:20:57Z","timestamp":1530220857000},"page":"515-525","source":"Crossref","is-referenced-by-count":46,"title":["Liquid Biopsies to Monitor Solid Organ Transplant Function: A Review of New Biomarkers"],"prefix":"10.1097","volume":"40","author":[{"given":"Jeroen G. H. P.","family":"Verhoeven","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam;"},{"name":"Division of Nephrology and Transplantation, Rotterdam Transplant Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Boer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam;"},{"name":"Division of Nephrology and Transplantation, Rotterdam Transplant Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron H. N.","family":"Van Schaik","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, Erasmus MC, University Medical Center Rotterdam, Rotterdam;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier C.","family":"Manintveld","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Transplantation, Rotterdam Transplant Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam;"},{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon M. H.","family":"Huibers","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla C.","family":"Baan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam;"},{"name":"Division of Nephrology and Transplantation, Rotterdam Transplant Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis A.","family":"Hesselink","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam;"},{"name":"Division of Nephrology and Transplantation, Rotterdam Transplant Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(14)61095-3","article-title":"Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial","volume":"384","author":"Haynes","year":"2014","journal-title":"Lancet."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med."},{"issue":"suppl 1","key":"R3-20230814","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/ajt.14562","article-title":"OPTN\/SRTR 2016 annual data report: lung","volume":"18","author":"Valapour","year":"2018","journal-title":"Am J Transpl."},{"issue":"suppl 1","key":"R4-20230814","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ajt.14557","article-title":"OPTN\/SRTR 2016 annual data report: kidney","volume":"18","author":"Hart","year":"2018","journal-title":"Am J Transpl."},{"issue":"suppl 1","key":"R5-20230814","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/ajt.14561","article-title":"OPTN\/SRTR 2016 annual data report: heart","volume":"18","author":"Colvin","year":"2018","journal-title":"Am J Transpl."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transpl."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury","volume":"380","author":"Bellomo","year":"2012","journal-title":"Lancet."},{"issue":"suppl 1","key":"R9-20230814","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/FTD.0000000000000239","article-title":"Graft-derived cell-free DNA as a marker of transplant graft injury","volume":"38","author":"Oellerich","year":"2016","journal-title":"Ther Drug Monit."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrneph.2013.281","article-title":"Biomarkers for kidney transplant rejection","volume":"10","author":"Lo","year":"2014","journal-title":"Nat Rev Nephrol."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1681\/ASN.2015010062","article-title":"Proteinuria as a noninvasive marker for renal allograft histology and failure: an observational cohort study","volume":"27","author":"Naesens","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2217\/bmm.14.56","article-title":"Biomarkers of acute rejection following cardiac transplantation","volume":"8","author":"McMinn","year":"2014","journal-title":"Biomark Med."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.transproceed.2011.03.010","article-title":"Complications of endomyocardial biopsy in heart transplant patients: a retrospective study of 2117 consecutive procedures","volume":"43","author":"Saraiva","year":"2011","journal-title":"Transpl Proc."},{"issue":"7 suppl","key":"R14-20230814","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1016\/j.healun.2005.04.001","article-title":"Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients","volume":"24","author":"Marboe","year":"2005","journal-title":"J Heart Lung Transpl."},{"key":"R15-20230814","first-page":"241","article-title":"Les acides nucleiques du plasma sanguin chez l'homme","volume":"142","author":"Mandel","year":"1948","journal-title":"C R Seances Soc Biol Fil."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer."},{"key":"R17-20230814","first-page":"181","article-title":"Circulating nucleic acids (CNAs) and cancer\u2013a survey","volume":"1775","author":"Fleischhacker","year":"2007","journal-title":"Biochim Biophys Acta."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinchem\/48.3.421","article-title":"Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation","volume":"48","author":"Lui","year":"2002","journal-title":"Clin Chem."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"e0184668","DOI":"10.1371\/journal.pone.0184668","article-title":"Acute effects of strength exercises and effects of regular strength training on cell free DNA concentrations in blood plasma","volume":"12","author":"Tug","year":"2017","journal-title":"PLoS One."},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00421-008-0827-2","article-title":"Effects of ultra-marathon on circulating DNA and mRNA expression of pro- and anti-apoptotic genes in mononuclear cells","volume":"104","author":"Atamaniuk","year":"2008","journal-title":"Eur J Appl Physiol."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/CCLM.2006.003","article-title":"Plasma cell-free DNA as an indicator of severity of injury in burn patients","volume":"44","author":"Chiu","year":"2006","journal-title":"Clin Chem Lab Med."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000440975","article-title":"The role of cell-free plasma DNA in critically ill patients with sepsis","volume":"41","author":"Clementi","year":"2016","journal-title":"Blood Purif."},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cellimm.2014.08.002","article-title":"Correlation between cell free DNA levels and medical evaluation of disease progression in systemic lupus erythematosus patients","volume":"292","author":"Tug","year":"2014","journal-title":"Cell Immunol."},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.gene.2016.06.033","article-title":"Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: a qualitative study","volume":"590","author":"Yao","year":"2016","journal-title":"Gene."},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10555-016-9629-x","article-title":"Origins, structures, and functions of circulating DNA in oncology","volume":"35","author":"Thierry","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1189\/jlb.4MR0316-108R","article-title":"Emerging roles of the processing of nucleic acids and toll-like receptors in innate immune responses to nucleic acids","volume":"101","author":"Miyake","year":"2017","journal-title":"J Leukoc Biol."},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(05)79055-3","article-title":"Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet."},{"key":"R29-20230814","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1373\/clinchem.2008.113530","article-title":"Presence of donor-derived DNA and cells in the urine of sex-mismatched hematopoietic stem cell transplant recipients: implication for the transrenal hypothesis","volume":"55","author":"Hung","year":"2009","journal-title":"Clin Chem."},{"key":"R30-20230814","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1111\/ajt.13387","article-title":"Cell-free DNA: an upcoming biomarker in transplantation","volume":"15","author":"Gielis","year":"2015","journal-title":"Am J Transpl."},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"241ra77","DOI":"10.1126\/scitranslmed.3007803","article-title":"Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection","volume":"6","author":"De Vlaminck","year":"2014","journal-title":"Sci Transl Med."},{"key":"R32-20230814","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1073\/pnas.1013924108","article-title":"Universal noninvasive detection of solid organ transplant rejection","volume":"108","author":"Snyder","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"R33-20230814","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.1073\/pnas.1517494112","article-title":"Noninvasive monitoring of infection and rejection after lung transplantation","volume":"112","author":"De Vlaminck","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"R34-20230814","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1373\/clinchem.2013.210328","article-title":"Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury","volume":"59","author":"Beck","year":"2013","journal-title":"Clin Chem."},{"key":"R35-20230814","doi-asserted-by":"crossref","first-page":"8589270","DOI":"10.1155\/2016\/8589270","article-title":"Chimerism analysis of cell-free DNA in patients treated with hematopoietic stem cell transplantation may predict early relapse in patients with hematologic malignancies","volume":"2016","author":"Aljurf","year":"2016","journal-title":"Biotechnol Res Int."},{"key":"R36-20230814","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrg.2017.12","article-title":"Transplant genetics and genomics","volume":"18","author":"Yang","year":"2017","journal-title":"Nat Rev Genet."},{"key":"R37-20230814","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1373\/clinchem.2005.058974","article-title":"Soluble donor DNA concentrations in recipient serum correlate with pancreas-kidney rejection","volume":"52","author":"Gadi","year":"2006","journal-title":"Clin Chem."},{"key":"R38-20230814","doi-asserted-by":"crossref","first-page":"e1002286","DOI":"10.1371\/journal.pmed.1002286","article-title":"Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: a prospective, observational, multicenter cohort study","volume":"14","author":"Schutz","year":"2017","journal-title":"PLoS Med."},{"key":"R39-20230814","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.transproceed.2015.08.035","article-title":"Donor-derived cell-free DNA is a novel universal biomarker for allograft rejection in solid organ transplantation","volume":"47","author":"Beck","year":"2015","journal-title":"Transpl Proc."},{"key":"R40-20230814","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/clinchem\/45.10.1741","article-title":"Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism","volume":"45","author":"Zhang","year":"1999","journal-title":"Clin Chem."},{"key":"R41-20230814","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"R43-20230814","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/cam4.1184","article-title":"Preanalytical blood sample workup for cell-free DNA analysis using droplet digital PCR for future molecular cancer diagnostics","volume":"6","author":"van Ginkel","year":"2017","journal-title":"Cancer Med."},{"key":"R44-20230814","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cca.2013.05.022","article-title":"Circulating cell free DNA: preanalytical considerations","volume":"424","author":"El Messaoudi","year":"2013","journal-title":"Clin Chim Acta."},{"key":"R45-20230814","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/1878-0261.12037","article-title":"Application of circulating tumor DNA in prospective clinical oncology trials\u2014standardization of preanalytical conditions","volume":"11","author":"van Dessel","year":"2017","journal-title":"Mol Oncol."},{"key":"R46-20230814","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/jnci\/dji432","article-title":"Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays","volume":"97","author":"Sozzi","year":"2005","journal-title":"J Natl Cancer Inst."},{"key":"R47-20230814","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1448.012","article-title":"Clinical relevance of circulating nucleosomes in cancer","volume":"1137","author":"Holdenrieder","year":"2008","journal-title":"Ann N Y Acad Sci."},{"key":"R48-20230814","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers9010005","article-title":"Circulating nucleosomes and nucleosome modifications as biomarkers in cancer","volume":"9","author":"McAnena","year":"2017","journal-title":"Cancers (Basel)."},{"key":"R49-20230814","doi-asserted-by":"crossref","first-page":"29654","DOI":"10.3390\/ijms161226180","article-title":"Histone methylation marks on circulating nucleosomes as novel blood-based biomarker in colorectal cancer","volume":"16","author":"Gezer","year":"2015","journal-title":"Int J Mol Sci."},{"key":"R50-20230814","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/00365513.2016.1190862","article-title":"Pre-analytical variables of circulating cell-free nucleosomes containing 5-methylcytosine DNA or histone modification H3K9Me3","volume":"76","author":"Rasmussen","year":"2016","journal-title":"Scand J Clin Lab Invest."},{"key":"R51-20230814","first-page":"1613","article-title":"Long-term stability of circulating nucleosomes in serum","volume":"30","author":"Holdenrieder","year":"2010","journal-title":"Anticancer Res."},{"key":"R52-20230814","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1083\/jcb.97.2.329","article-title":"Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes","volume":"97","author":"Harding","year":"1983","journal-title":"J Cell Biol."},{"key":"R53-20230814","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrneph.2017.98","article-title":"Extracellular vesicles in renal disease","volume":"13","author":"Karpman","year":"2017","journal-title":"Nat Rev Nephrol."},{"key":"R54-20230814","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fimmu.2015.00203","article-title":"Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications","volume":"6","author":"De Toro","year":"2015","journal-title":"Front Immunol."},{"key":"R55-20230814","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCRESAHA.110.226456","article-title":"Microparticles: protagonists of a novel communication network for intercellular information exchange","volume":"107","author":"Mause","year":"2010","journal-title":"Circ Res."},{"key":"R56-20230814","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.leu.2404296","article-title":"Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia."},{"key":"R57-20230814","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fcell.2016.00083","article-title":"Stem cell-derived extracellular vesicles and immune-modulation","volume":"4","author":"Burrello","year":"2016","journal-title":"Front Cell Dev Biol."},{"key":"R58-20230814","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ki.2008.206","article-title":"Urinary exosomal transcription factors, a new class of biomarkers for renal disease","volume":"74","author":"Zhou","year":"2008","journal-title":"Kidney Int."},{"key":"R59-20230814","doi-asserted-by":"crossref","first-page":"F553","DOI":"10.1152\/ajprenal.00056.2013","article-title":"Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury","volume":"305","author":"Zhou","year":"2013","journal-title":"Am J Physiol Ren Physiol."},{"key":"R60-20230814","doi-asserted-by":"crossref","first-page":"e60177","DOI":"10.1371\/journal.pone.0060177","article-title":"Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria","volume":"8","author":"Kalani","year":"2013","journal-title":"PLoS One."},{"key":"R61-20230814","doi-asserted-by":"crossref","first-page":"e104490","DOI":"10.1371\/journal.pone.0104490","article-title":"Urinary CD133+ extracellular vesicles are decreased in kidney transplanted patients with slow graft function and vascular damage","volume":"9","author":"Dimuccio","year":"2014","journal-title":"PLoS One."},{"key":"R62-20230814","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1016\/j.transproceed.2013.08.079","article-title":"Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantation","volume":"45","author":"Alvarez","year":"2013","journal-title":"Transpl Proc."},{"key":"R63-20230814","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI87993","article-title":"Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue","volume":"127","author":"Vallabhajosyula","year":"2017","journal-title":"J Clin Invest."},{"key":"R64-20230814","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cyto.a.22795","article-title":"Analytical challenges of extracellular vesicle detection: a comparison of different techniques","volume":"89","author":"Erdbrugger","year":"2016","journal-title":"Cytometry A."},{"key":"R65-20230814","doi-asserted-by":"crossref","first-page":"e11469","DOI":"10.1371\/journal.pone.0011469","article-title":"Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg)","volume":"5","author":"Szajnik","year":"2010","journal-title":"PLoS One."},{"key":"R66-20230814","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v2i0.20360","article-title":"Standardization of sample collection, isolation and analysis methods in extracellular vesicle research","volume":"2","author":"Witwer","year":"2013","journal-title":"J Extracell Vesicles."},{"key":"R67-20230814","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jim.2016.08.007","article-title":"The impact of various preanalytical treatments on the phenotype of small extracellular vesicles in blood analyzed by protein microarray","volume":"438","author":"Baek","year":"2016","journal-title":"J Immunol Methods."},{"key":"R68-20230814","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm0598-594","article-title":"Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes","volume":"4","author":"Zitvogel","year":"1998","journal-title":"Nat Med."},{"key":"R69-20230814","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1158\/0008-5472.CAN-06-3456","article-title":"Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2","volume":"67","author":"Clayton","year":"2007","journal-title":"Cancer Res."},{"key":"R70-20230814","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3747\/co.v16i3.367","article-title":"Exosomes in tumour immunity","volume":"16","author":"Clayton","year":"2009","journal-title":"Curr Oncol."},{"key":"R71-20230814","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/01.TP.0000092494.75313.38","article-title":"Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection","volume":"76","author":"Peche","year":"2003","journal-title":"Transplantation."},{"issue":"suppl 1","key":"R72-20230814","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/FTD.0000000000000287","article-title":"Barcelona consensus on biomarker-based immunosuppressive drugs management in solid organ transplantation","volume":"38","author":"Brunet","year":"2016","journal-title":"Ther Drug Monit."},{"key":"R73-20230814","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1681\/ASN.2017010004","article-title":"Precision transplant medicine: biomarkers to the rescue","volume":"29","author":"Naesens","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"R74-20230814","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1111\/ajt.12285","article-title":"Cross-validation of IFN-gamma Elispot assay for measuring alloreactive memory\/effector T cell responses in renal transplant recipients","volume":"13","author":"Bestard","year":"2013","journal-title":"Am J Transpl."},{"key":"R75-20230814","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/FTD.0000000000000044","article-title":"Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation","volume":"36","author":"Oellerich","year":"2014","journal-title":"Ther Drug Monit."},{"key":"R76-20230814","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13148-015-0139-4","article-title":"Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer","volume":"7","author":"Bauden","year":"2015","journal-title":"Clin Epigenetics."},{"key":"R77-20230814","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1600-6143.2008.02532.x","article-title":"Kidney transplantation decreases the level and procoagulant activity of circulating microparticles","volume":"9","author":"Al-Massarani","year":"2009","journal-title":"Am J Transpl."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201810000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:22:36Z","timestamp":1692051756000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201810000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000549","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}